Premises:1 Event time and novelty determine which variance an option can capture.2 Calltime is not firstrelease; clinicalresults are not FDA decisions.3 Fundamental surprise needs independently validated cheapoptionexpressions. Primarycalendar observations recorded separately with URLs and publicationdates. Sep8: INBX08ETclinicalcall; QFR10ET; NYFedSCE11ET; Fedcredit15ET; BRZE/CASYafterclose; GMEdateonlycompleteQ2. Sep9: CHWY/ASObeforeopen,CHWY08ET/ASO10ETcalls; TYRA/IRD08ETclinicalcalls; CASY08:30ETcall afterprior-eveningresults; ECEC+Services10ET. PPI/CPI Sep10/11 outsidewindow. BoundedFDAsearch verified no Sep8/9deadline; not comprehensive guarantee and spontaneous decisions remain possible. GME Aug31 already supplies sales780–800m andoperatingincome150–170m; netincome290–310m includesapproximately238meBaygain minus75mdigitalassetloss. Netmark163m roughly54.3% of300mnetincome midpoint is descriptive before tax/other reconciliation, NOT clean adjustedearnings. Firstread completeoperatingbridge/cash/investmentexposure; a repeatofranges supplieslessnovelty than anordinaryearningsdate. Strongcountercase unforeseen guidance/capitalallocation changes can stillcreatebiggaps,so preannouncementdoesnotprove lowIVfair. CHWY frozen16event2022–25RMS10.3956% retained frommemory, notrefit; Sep8closebaseline needed,15:40reviewisnotclose. Issuers closest to own timetable but publicity is not independent verificationof economicedge. Sources include https://investor.gamestop.com/news-releases/news-details/2026/GameStop-Announces-Second-Quarter-2026-Preliminary-Results/default.aspx ; https://investor.chewy.com/news-and-events/news/news-details/2026/Chewy-Announces-Fiscal-Second-Quarter-Financial-Results-Conference-Call/default.aspx ; https://www.census.gov/economic-indicators/calendar-listview.html ; https://www.bls.gov/schedule/2026/ ; all8issuer URLs inobservations. No newbinarypositionorautomaticentry.
sessions2
GME_sales_low_m780
GME_sales_high_m800
GME_operating_income_low_m150
GME_operating_income_high_m170
GME_net_marks_m163
verified_FDA_deadlines0
allocation0
06UTC TLT duration supports a scenario magnitude, not a cheap-put conclusion
Premises:1 Underlying exposure must support the price scenario.2 Income distributions affect option parity and raw-price paths.3 Yield and duration are not an option forecast. Issuer Sep4 price82.21,NAV82.17,effective duration15.06years; Sep3SECyield5.17%,trailingyield4.74%,monthlydistributions,expense.15%. A +10bp parallel yield shock implies roughly-1.506% or-$1.23808 before convexity/carry, comparable to measured2ATR1.297514. This makes a twoATR bearish scenario economically possible but supplies neither its probability nor its timing. Monthly cash requires discrete ex-div dates for a final American-option model; continuousq0–5% pricing range and simulationq4.74% are proxies. Baseline short-horizon variance9.6648% sigma may miss a rate jump, strongest counterargument to rejecting cheap convexity; no verified surprise or current executablequote establishes that jump. Rate shock -> long-duration bonds reprice -> volatility/optionIV can rise while higher future income offsets some totalreturn; later meanreversion or carry can erase put gains. Holdcash pending netoptionedge. Source https://www.ishares.com/us/products/239454/ishares-20-year-treasury-bond-etf ; https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=TLT&feed=sip&adjustment=all . Issuer source nearest fund exposure, not independent forecast of interest rates.
price82.21
NAV82.17
duration15.06
trailing_yield_pct4.74
SEC_yield_pct5.17
ten_bp_price_effect_pct-1.51
two_ATR1.3
allocation0
PATH business evidence permits persistent uncertainty but does not price its puts
Premises: 1 Business risk can persist after earnings; counterexample to automatic volatility decay is deteriorating renewals or rising platform costs. 2 Current operating strength does not establish stock fair value or future tail frequency. 3 A dated no-dividend policy supports a model input, not irrevocable cash rights. September3 issuer Q2 disclosure is positive framing; GAAP operating margin7.80% and OCF margin7.56% temper extrapolation from80% gross margin. ARR is not revenue guidance. March25 FY2026 10K identifies renewal and third-party infrastructure dependencies and no anticipated dividends. Thus persistent business uncertainty and a one-off earnings repricing can both be true. No enterprise-value estimate from weighted-average shares; current shares and full debt adjustments were not verified. Unit-economics and tail-probability mapping remains absent. Transcript403 limits causal attribution. These sources do not turn a bearish narrative into cheap optionality. Sources https://ir.uipath.com/news/detail/461/uipath-reports-second-quarter-fiscal-2027-financial-results ; https://ir.uipath.com/financials/sec-filings/content/0001734722-26-000012/path-20260131.htm .
revenue_m410
GAAP_operating_margin_pct7.8
OCF_margin_pct7.56
liquid_resources_m1405
allocation0
Primary checks on widened leads: post-event volatility and cash definitions
Premises:1 Large observed ranges may reflect completed news rather than unpriced future uncertainty.2 Operating growth does not determine option fair value without future return distribution and ask-to-bid costs.3 Cross-market fund NAV uses valuation timing distinct from local closes. IOT Sep3 issuer quarter endedAug1: revenue508.437m,ARR2124.7m +30%;GAAP operating4.875m versusadjusted106m,FCF64.7m versusSBC96.385m. Calculate GAAP operating margin0.959%;SBC/revenue18.96%. Underlying Sep4 IEX range14.43% follows released results; raising diffusion forecast from this gap risks treating completed catalyst as recurrent. SNDK Aug5 issuer:Q4revenue8965m,+51%q/q mostlypricing;84.6%GM;FCF7083m vs adjusted5035m after110mJV and1938mcustomerpayment deductions. Gross cash should not be capitalized as recurring without adjustments. Sep4IEXclose1739.915/FYGAAPEPS73.76 gives23.59x trailing reportedEPS, not prospective fairvalue; high cyclicalmargins maynormalize. EWJ issuerSep4NAV98.07,close98.28,premium0.22%,PE19.26; systematicfairvaluation means Japan/NYclock mismatch not parity. Strong countercase: durable customer adoption or contracted memorypayments could sustain growth and futurevol; that is a hypothesis, not known optionedge. Soundness based on original issuer documents, economically interested sources; no independent customer validation obtained. Facts end at historical figures; distributions/cash durability are assumptions. These checks constrain model interpretation, do not justify stock purchases outside mispricing mandate. Sources https://www.sec.gov/Archives/edgar/data/1642896/000162828026060438/samsaraepr-q22027.htm ; https://investor.sandisk.com/news-releases/news-release-details/sandisk-reports-fiscal-fourth-quarter-2026-financial-results ; https://www.ishares.com/us/products/239665/ishares-msci-japan-etf .
IOT_GAAP_margin_pct0.96
IOT_SBC_revenue_pct18.96
SNDK_FCF_m7083
SNDK_adjusted_FCF_m5035
SNDK_trailing_PE23.59
EWJ_premium_pct0.22
September8–9 primary calendar: distinguish remaining uncertainty from scheduled news
Premises:1 Event model must align firstpublicnews.2 Preannounced results reduce the amount of wholly unknown information, without necessarily eliminating event risk.3 Clinicalreadouts are not FDAdecisions. Primary issuer/agency observations8889–8904 datedSep7, eachorigin countedonce. Sep8 INBX08ETclinicalwebcast; CensusQ2QFR10ET, NYFedSCE11ET, FedG19consumercredit15ET; BRZEafterclose/16:30ETcall; GMEcompleteresultsdateonly. Sep9 CHWYbeforeopen/08ETcall,ASObeforeopen/10ETcall,TYRA08ETclinicalwebcast; JuneECEC/Q2QSS10ET; EIASTEOdateonly. PPI/CPI Sep10/11,TLXPixclaraSep11 outsidewindow; no exhaustiveFDAabsenceclaim. CASYSep8afterclose andIRD/InditexSep9 remaincontext, not independentlyrevalidated thisrun; CASYPDF200 but readerunavailable. GMEAug31 unauditedQ2sales780–800m versus972.2m,operatingincome150–170m versus66.4m; netincome290–310m includes238meBaygain/75mdigitalloss. Inference: unconditional past earningsgap variance may not describe residualSep8uncertainty. Counterexample: completefilings/newguidance may still moveprice materially, so no zeroeventvarianceassumption. No issuervaluation or per-name optioncandidate inferred; insufficientcurrentfundamental/chainaudit prevents promotion. Sources https://investor.gamestop.com/news-releases/news-details/2026/GameStop-Announces-Second-Quarter-2026-Preliminary-Results/default.aspx ; https://www.census.gov/economic-indicators/calendar-listview.html ; https://www.bls.gov/schedule/2026/ ; https://www.federalreserve.gov/newsevents/2026-september.htm ; https://www.newyorkfed.org/research/calendars/i-sep26.html ; https://www.eia.gov/outlooks/steo/outlook.php ; exact issuer URLs inobservations8894–8902. Promotionalclaims not adopted; dates are plans not realized surprises. First attempt to record failed overlong figurekey; this is corrected record.
sessions2
GME_sales_low_m780
GME_sales_high_m800
GME_opinc_low_m150
GME_opinc_high_m170
GME_ebay_gain_m238
GME_digital_loss_m75
allocation0
FRO dividend classification: quarterly cash drop differs from conditional special distribution
Premises:1 XLF owns sector equities, so an inexpensive ETF valuation is not independently an inexpensive option;2 trailing distribution yield is an approximation for option carry, not a confirmed cash dividend;3 issuerNAV andstockquote comparisons need same date. Sep3 issuer76holdings,forwardPE16.32,PB2.48,distributionyield1.38%,expense.08% annual,NAV58.54,AUM55.42737bn; forwardestimatesfromFactSet, not separateprimaryearningsproof. Source https://www.ssga.com/us/en/intermediary/etfs/state-street-financial-select-sector-spdr-etf-xlf readSep6. Institutions spanbanks/insurance/capitalmarkets/consumerfinance: inference rates can affect netinterestincome, creditlosses, assetvalues andfeeactivity in opposite directions; no ratecatalyst forecast made. Expense rate .0008 implies ~.00001587 over5/252year and~$881.39 annual on hypothetical1.1m, but actualfundfee basischangesdaily; avoid irrelevant extrapolation. For account127.65 annual expense exposure at constantbalance would .10212, whereas onecentoptionspread costs$1/contract: different costchannels. We useq=.0138 as sensitivity input, r=.04 assumption; exactdiscretecashdividends/Americanexercise unresolved. Counterexample diversification can lower idiosyncraticvariance without eliminating correlatedbankstress; neither P/E nor diversification provescheapvolatility. No moneyallocated.
holdings76
forward_PE16.32
price_book2.48
expense_pct0.08
distribution_yield_pct1.38
NAV58.54
AUM_million55427.37
fund_balance127.65
annual_expense_on_balance0.1
onecent_contract_spread1
NFLX event economics: split mechanics and merger cash do not forecast a September put payoff
Premises: (1) QQQ tracksNasdaq100 before expenses and is non-diversified; (2) concentration permits common-factor shocks; (3) shocks can be down as well as up, and are not evidence an offered call is cheap. PrimaryDec19 2025 issuer filing https://www.sec.gov/Archives/edgar/data/1067839/000110465925123273/tm2529177d1_485bpos.htm states0.18% annual expenses and technology concentration as ofOct31 2025, and reclassification to open-end management company. It supersedes older unit-investment-trust descriptions. Do not extrapolate dated holdings into exactSep2026 weights. Fundamental bear case: growth expectations can be priced into both equities and calls; adverse rates or earnings can reduce stock prices while increasing put volatility. No company cashflow/valuation edge or new weekend fundamental change independently established; do not invent them from supplied media headlines. Cost rate0.18% annual is about0.00197% over4calendar days under linear accrual, far below observed option spreads; trading variance-clock and feed quality are binding instead. ETF pricing is not a corporateDCF task. Conclusion supports no call purchase; current dividends/discrete ex-dates would be required for tighter parity pricing, and are not assumed verified.